BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Coformycin

A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.

171+ PubMed studies analyzed · Evidence Score: 38.9

Research Domains

Coformycin has been studied across 16 research domains including 🔬 Oncology, 🧠 Focus & Attention, 🫁 Liver & Detox, 🫘 Kidney, 😴 Sleep. The primary research focus is 🔬 Oncology with 12% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Coformycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

magnolia
2 shared targets
dimocarpus
2 shared targets
dendrobium
2 shared targets
lycopus
2 shared targets
gentiana
2 shared targets
platycodon
2 shared targets
gastrodia
2 shared targets
albizia
2 shared targets
alisma
2 shared targets
allium
2 shared targets
Loading evidence profile...

This evidence profile for Coformycin is generated deterministically from 171 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.